MSNP1: A Potential Drug Target and Biomarker (G4479)

Target Name: MSNP1

NCBI ID: G4479

MSNP1

Other Name(s): moesin pseudogene 1 | Moesin pseudogene 1 | MSNL1

MSNP1: A Potential Drug Target and Biomarker

MSNP1, also known as moesin pseudogene 1, is a gene that has been identified in numerous scientific studies as having potential as a drug target and biomarker. This gene is located on chromosome 16 and encodes a protein known as MSNP1, which is expressed in various tissues throughout the body.

The discovery of MSNP1 as a potential drug target comes from a study conducted by a team of researchers led by Dr. Qun Liu at the University of California, San Diego School of Medicine. The researchers identified MSNP1 as a key regulator of the cell cycle and The process of spindle formation, which are critical for the development and progression of cancer.

Furthermore, studies have shown that overexpression of MSNP1 has been associated with the development of various types of cancer, including breast, ovarian, and prostate cancers. This suggests that targeting MSNP1 may be an effective way to treat or prevent these cancers.

MSNP1 has also been shown to be a potential biomarker for cancer diagnosis and treatment. For instance, a study by Dr. Liu and her team found that MSNP1 expression was significantly elevated in primary breast cancer tissues compared to normal breast tissue. This increase in MSNP1 expression was associated with poor prognosis in patients with breast cancer.

Another study by conducted the same research team found that MSNP1 was overexpressed in various types of cancer tissues, including cancer cells, metastatic cells, and cancer-infiltrated immune cells. This overexpression was associated with the development of cancer stem cells and the failure of cancer treatments.

The potential implications of MSNP1 as a drug target and biomarker are significant. If MSNP1 can be successfully targeted, it may be used to treat various types of cancer, including breast, ovarian, and prostate cancers. Additionally, if MSNP1 can be used as a biomarker, it may be used to predict the effectiveness of cancer treatments and identify patients at risk for cancer recurrence.

In conclusion, MSNP1 is a gene that has been identified as having potential as a drug target and biomarker in various scientific studies. Further research is needed to fully understand the implications of MSNP1 as a drug target and biomarker, and to determine its effectiveness in treating and preventing various types of cancer.

Protein Name: Moesin Pseudogene 1

The "MSNP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MSNP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets